Thomas P. C. Dorlo

MedicineImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors”.

Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors

Cancer Chemotherapy and Pharmacology(2020)10.1007/s00280-020-04134-9

N/A

0.730DataRank · unranked

20 citations

Alwin D. R. Huitema, Thomas P. C. Dorlo, Cody J. Peer, Lisa M. Cordes, Linda Sciuto +6 more

Editorial: Emerging talents in Frontiers in Pharmacology: Drug metabolism and transport 2022

Frontiers in Pharmacology(2022)10.3389/fphar.2022.1083163

N/A

0DataRank · unranked

1 citations

Massimo Valoti, Yurong Lai, Thomas P. C. Dorlo, Yan Li, Terry D. Hinds

Determining tissue distribution of the oral antileishmanial agent miltefosine: a physiologically-based pharmacokinetic modeling approach

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00328-24

N/A

0DataRank · unranked

3 citations

Sihyung Yang, Thomas P. C. Dorlo, Michael Zhuo Wang, Bhargavi Srija Ramisetty